CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C19104 | BRD-K52310606 | BRD-K52310606 | -- | -- | -- | Details |
| C19105 | BRD-K52313696 | tacedinaline | -- | -- | -- | Details |
| C19106 | BRD-K52319351 | BRD-K52319351 | -- | -- | -- | Details |
| C19107 | BRD-K52321331 | BRD-K52321331 | -- | -- | -- | Details |
| C19108 | BRD-K52335877 | BRD-K52335877 | -- | -- | -- | Details |
| C19109 | BRD-K52339692 | BRD-K52339692 | -- | -- | -- | Details |
| C19110 | BRD-K52339742 | BRD-K52339742 | -- | -- | -- | Details |
| C19111 | BRD-K52340217 | BRD-K52340217 | -- | -- | -- | Details |
| C19112 | BRD-K52341396 | BRD-K52341396 | -- | -- | -- | Details |
| C19113 | BRD-K52341452 | BRD-K52341452 | -- | -- | -- | Details |
| C19114 | BRD-K52342362 | BRD-K52342362 | -- | -- | -- | Details |
| C19115 | BRD-K52353085 | BRD-K52353085 | -- | -- | -- | Details |
| C19116 | BRD-K52354895 | BRD-K52354895 | -- | -- | -- | Details |
| C19117 | BRD-K52356070 | BRD-K52356070 | -- | -- | -- | Details |
| C19118 | BRD-K52361779 | BRD-K52361779 | -- | -- | -- | Details |
| C19119 | BRD-K52369815 | BRD-K52369815 | -- | -- | -- | Details |
| C19120 | BRD-K52371706 | BRD-K52371706 | -- | -- | -- | Details |
| C19121 | BRD-K52372795 | BRD-K52372795 | -- | -- | -- | Details |
| C19122 | BRD-K52373488 | BRD-K52373488 | -- | -- | -- | Details |
| C19123 | BRD-K52373514 | BRD-K52373514 | -- | -- | -- | Details |
| C19124 | BRD-K52379384 | BRD-K52379384 | -- | -- | -- | Details |
| C19125 | BRD-K52379519 | BRD-K52379519 | -- | -- | -- | Details |
| C19126 | BRD-K52383401 | BRD-K52383401 | -- | -- | -- | Details |
| C19127 | BRD-K52391588 | BRD-K52391588 | -- | -- | -- | Details |
| C19128 | BRD-K52394958 | GR-159897 | TAC1; TACR2 | Tachykinin antagonist | -- | Details |
| C19129 | BRD-K52397688 | amperozide | DRD2; HTR2A | Dopamine receptor antagonist | -- | Details |
| C19130 | BRD-K52403446 | BRD-K52403446 | -- | -- | -- | Details |
| C19131 | BRD-K52403701 | BRD-K52403701 | -- | -- | -- | Details |
| C19132 | BRD-K52405437 | penitrem-a | KCNMA1 | Potassium channel blocker | -- | Details |
| C19133 | BRD-K52406139 | BRD-K52406139 | -- | -- | -- | Details |
| C19134 | BRD-K52413350 | BRD-K52413350 | -- | -- | -- | Details |
| C19135 | BRD-K52413425 | dibutyltin-diacetate | -- | -- | -- | Details |
| C19136 | BRD-K52414345 | BRD-K52414345 | -- | -- | -- | Details |
| C19137 | BRD-K52416366 | BRD-K52416366 | -- | -- | -- | Details |
| C19138 | BRD-K52418167 | BRD-K52418167 | -- | -- | -- | Details |
| C19139 | BRD-K52420542 | GSK-591 | -- | -- | -- | Details |
| C19140 | BRD-K52421542 | BRD-K52421542 | -- | -- | -- | Details |
| C19141 | BRD-K52423731 | BRD-K52423731 | -- | -- | -- | Details |
| C19142 | BRD-K52424224 | BRD-K52424224 | -- | -- | -- | Details |
| C19143 | BRD-K52428486 | BRD-K52428486 | -- | -- | -- | Details |
| C19144 | BRD-K52431530 | josamycin | -- | -- | -- | Details |
| C19145 | BRD-K52435112 | BRD-K52435112 | -- | -- | -- | Details |
| C19146 | BRD-K52436508 | BRD-K52436508 | -- | -- | -- | Details |
| C19147 | BRD-K52436943 | SR-144528 | CNR2 | Cannabinoid receptor inverse agonist | -- | Details |
| C19148 | BRD-K52441396 | BRD-K52441396 | -- | -- | -- | Details |
| C19149 | BRD-K52446745 | BRD-K52446745 | -- | -- | -- | Details |
| C19150 | BRD-K52453128 | BRD-K52453128 | -- | -- | -- | Details |
| C19151 | BRD-K52457887 | BRD-K52457887 | -- | -- | -- | Details |
| C19152 | BRD-K52459643 | alprostadil | PTGER1; PTGER2 | Prostanoid receptor agonist | -- | Details |
| C19153 | BRD-K52460145 | BRD-K52460145 | -- | -- | -- | Details |
| C19154 | BRD-K52463977 | BRD-K52463977 | -- | -- | -- | Details |
| C19155 | BRD-K52465094 | BRD-K52465094 | -- | -- | -- | Details |
| C19156 | BRD-K52468146 | BRD-K52468146 | -- | -- | -- | Details |
| C19157 | BRD-K52468958 | BRD-K52468958 | -- | -- | -- | Details |
| C19158 | BRD-K52473019 | BRD-K52473019 | -- | -- | -- | Details |
| C19159 | BRD-K52473839 | BRD-K52473839 | -- | -- | -- | Details |
| C19160 | BRD-K52476750 | BRD-K52476750 | -- | -- | -- | Details |
| C19161 | BRD-K52492854 | BRD-K52492854 | -- | -- | -- | Details |
| C19162 | BRD-K52497027 | BRD-K52497027 | -- | -- | -- | Details |
| C19163 | BRD-K52500055 | BRD-K52500055 | -- | -- | -- | Details |
| C19164 | BRD-K52512893 | SC-19220 | PTGER1 | Prostanoid receptor antagonist | -- | Details |
| C19165 | BRD-K52515416 | BRD-K52515416 | -- | -- | -- | Details |
| C19166 | BRD-K52520268 | BRD-K52520268 | -- | -- | -- | Details |
| C19167 | BRD-K52522949 | NCH-51 | HDAC6; HDAC5; HDAC1; HDAC2; HDAC7; HDAC8; HDAC11; HDAC10; HDAC3; HDAC9; HDAC4 | HDAC inhibitor | -- | Details |
| C19168 | BRD-K52524742 | BRD-K52524742 | -- | -- | -- | Details |
| C19169 | BRD-K52532740 | BRD-K52532740 | -- | -- | -- | Details |
| C19170 | BRD-K52536034 | BRD-K52536034 | -- | -- | -- | Details |
| C19171 | BRD-K52540534 | BRD-K52540534 | -- | -- | -- | Details |
| C19172 | BRD-K52542879 | BRD-K52542879 | -- | -- | -- | Details |
| C19173 | BRD-K52544910 | BRD-K52544910 | -- | -- | -- | Details |
| C19174 | BRD-K52551495 | BRD-K52551495 | -- | -- | -- | Details |
| C19175 | BRD-K52552873 | BRD-K52552873 | -- | -- | -- | Details |
| C19176 | BRD-K52560704 | methylstat | -- | -- | -- | Details |
| C19177 | BRD-K52564648 | BRD-K52564648 | -- | -- | -- | Details |
| C19178 | BRD-K52566202 | BRD-K52566202 | -- | -- | -- | Details |
| C19179 | BRD-K52570793 | BRD-K52570793 | -- | -- | -- | Details |
| C19180 | BRD-K52572235 | BRD-K52572235 | -- | -- | -- | Details |
| C19181 | BRD-K52574175 | BRD-K52574175 | -- | -- | -- | Details |
| C19182 | BRD-K52577250 | SA-1459291 | -- | -- | -- | Details |
| C19183 | BRD-K52582315 | BRD-K52582315 | -- | -- | -- | Details |
| C19184 | BRD-K52592505 | BRD-K52592505 | -- | -- | -- | Details |
| C19185 | BRD-K52593146 | BRD-K52593146 | -- | -- | -- | Details |
| C19186 | BRD-K52595962 | BRD-K52595962 | -- | -- | -- | Details |
| C19187 | BRD-K52602815 | BRD-K52602815 | -- | -- | -- | Details |
| C19188 | BRD-K52613522 | BRD-K52613522 | -- | -- | -- | Details |
| C19189 | BRD-K52618540 | inositol | CDIPT | Insulin sensitizer | -- | Details |
| C19190 | BRD-K52620056 | BRD-K52620056 | -- | -- | -- | Details |
| C19191 | BRD-K52620403 | STO-609 | CAMKK2; CAMKK1 | Calmodulin antagonist | -- | Details |
| C19192 | BRD-K52628302 | BRD-K52628302 | -- | -- | -- | Details |
| C19193 | BRD-K52630978 | BRD-K52630978 | -- | -- | -- | Details |
| C19194 | BRD-K52634604 | BRD-K52634604 | -- | -- | -- | Details |
| C19195 | BRD-K52640952 | BRD-K52640952 | PLA2G1B | Topoisomerase inhibitor | -- | Details |
| C19196 | BRD-K52643239 | BRD-K52643239 | -- | -- | -- | Details |
| C19197 | BRD-K52643615 | BRD-K52643615 | -- | -- | -- | Details |
| C19198 | BRD-K52647340 | BRD-K52647340 | -- | -- | -- | Details |
| C19199 | BRD-K52651393 | BRD-K52651393 | -- | -- | -- | Details |
| C19200 | BRD-K52653383 | BRD-K52653383 | -- | -- | -- | Details |
| C19201 | BRD-K52654243 | BRD-K52654243 | -- | -- | -- | Details |
| C19202 | BRD-K52656828 | BRD-K52656828 | -- | -- | -- | Details |
| C19203 | BRD-K52657367 | BRD-K52657367 | -- | -- | -- | Details |